Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 20/20 | 0.57 |
| ▸ | RXRG | P48443 | 8/20 | 0.57 |
| ▸ | RXRB | P28702 | 7/20 | 0.57 |
| ▸ | RARB | P10826 | 5/20 | 0.57 |
| ▸ | RARG | P13631 | 4/20 | 0.57 |
| ▸ | RARA | P10276 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.57 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | PGR | P06401 | 1/20 | 0.57 |
| ▸ | HTR1A | P08908 | 1/20 | 0.57 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.57 |
| ▸ | DRD1 | P21728 | 1/20 | 0.57 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8028114 | 0.82 | RXRA (0.54) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8026158 | 0.82 | RXRA (0.54) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8025901 | 0.81 | RXRA (0.52) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL6752834 | 0.80 | RXRA (0.59) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8015896 | 0.80 | RXRA (0.59) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8026774 | 0.78 | RXRA (0.54) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8026590 | 0.77 | RXRA (0.53) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8031537 | 0.77 | RXRA (0.50) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8030273 | 0.76 | RXRA (0.51) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8026146 | 0.74 | RXRA (0.49) | RXRARXRGRXRBRARBRARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1173061-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES | Bristol-Myers Squibb Company (US) | 2002-01-23 | — | — | EP | claimed |
| WO-2000064260-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-11-02 | — | — | WO | claimed |
| WO-2002022113-A2 | RETINOIC ACID RECEPTOR ANTAGONISTS AS PROMOTERS OF ANGIOGENESIS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-03-21 | — | — | WO | disclosed |
| EP-1173061-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES | Bristol-Myers Squibb Company (US) | 2002-01-23 | — | — | EP | disclosed |
| WO-2001078700-A2 | COMPOSITIONS FOR USE IN MODULATING IMMUNE SYSTEM FUNCTION COMPRISING AT LEAST ONE RETRINOID AND AT LEAST ONE CYTOKINE | GEISSMANN FREDERIC (FR) | 2001-10-25 | — | — | WO | disclosed |
| WO-2000064260-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-11-02 | — | — | WO | disclosed |